Journal
IMMUNOLOGY TODAY
Volume 21, Issue 1, Pages 24-28Publisher
ELSEVIER SCI LTD
DOI: 10.1016/S0167-5699(99)01541-8
Keywords
-
Categories
Ask authors/readers for more resources
Recently, much has been learned about the immunology of multiple sclerosis (MS). However, a mechanistic understanding of currently employed immunomodulatory therapies has lagged behind, hindering both the search for more effective agents and clearer insight into the immunopathogenesis of MS. Christopher Karp and colleagues explore a unifying hypothesis for the mechanism of action of interferon beta in MS: suppression of interleukin 12 production.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available